U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.382C>T (p.Pro128Ser) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Aug 14, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001354376.5

Allele description [Variation Report for NM_000465.4(BARD1):c.382C>T (p.Pro128Ser)]

NM_000465.4(BARD1):c.382C>T (p.Pro128Ser)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.382C>T (p.Pro128Ser)
HGVS:
  • NC_000002.12:g.214781492G>A
  • NG_012047.3:g.33220C>T
  • NM_000465.4:c.382C>TMANE SELECT
  • NM_001282543.2:c.325C>T
  • NM_001282545.2:c.215+15569C>T
  • NM_001282548.2:c.158+27920C>T
  • NM_001282549.2:c.364+10805C>T
  • NP_000456.2:p.Pro128Ser
  • NP_001269472.1:p.Pro109Ser
  • LRG_297t1:c.382C>T
  • LRG_297:g.33220C>T
  • LRG_297p1:p.Pro128Ser
  • NC_000002.11:g.215646216G>A
  • NG_012047.2:g.33213C>T
  • NM_000465.2:c.382C>T
  • NM_000465.3:c.382C>T
  • NR_104212.2:n.347C>T
  • NR_104215.2:n.290C>T
Protein change:
P109S
Links:
dbSNP: rs878854011
NCBI 1000 Genomes Browser:
rs878854011
Molecular consequence:
  • NM_001282545.2:c.215+15569C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282548.2:c.158+27920C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282549.2:c.364+10805C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000465.4:c.382C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282543.2:c.325C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104212.2:n.347C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.290C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001548981Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Uncertain significanceunknownclinical testing

SCV004012379GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Aug 14, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001548981.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The BARD1 p.Pro128Ser variant was not identified in the literature nor was it identified in the Cosmic, MutDB, and the Zhejiang Colon Cancer databases. The variant was identified in dbSNP (ID: rs878854011) as “with uncertain significance allele”, in the ClinVar database as likely benign by Invitae and as uncertain significance by Ambry Genetics. The variant was not identified in the 1000 Genomes Project or in the NHLBI GO Exome Sequencing Project databases. The variant was identified in control databases in 3 of 273386 chromosomes at a frequency of 0.00001 (Genome Aggregation Database Feb 27, 2017). It was observed in the European Non-Finnish population in 3 of 124658 chromosomes (freq: 0.00002); the was not observed in the African, Other, Latino, Ashkenazi Jewish, East Asian, European Finnish, and South Asian populations. The p.Pro128Ser residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The identification of this variant in an individual from our laboratory with a co-occurring pathogenic variant (ATM, EXON49, c.7271T>G), in the context of a breast cancer referral, albeit in a different gene, increased the likelihood the BARD1 p.Pro128Ser may not have clinical significance. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV004012379.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024